Roivant Sciences Ltd. Quarterly Debt-to-equity in % from Q4 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Roivant Sciences Ltd. quarterly Debt-to-equity history and growth rate from Q4 2021 to Q3 2024.
Roivant Sciences Ltd. Debt-to-equity for the quarter ending September 30, 2024 was 12.1 %, a 84.6% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	12.1	-66	-84.6%	Sep 30, 2024
Q2 2024	15.4	-57.8	-78.9%	Jun 30, 2024
Q1 2024	21.9	-44.3	-66.9%	Mar 31, 2024
Q4 2023	33.5	-21.2	-38.8%	Dec 31, 2023
Q3 2023	78	+35.6	+83.7%	Sep 30, 2023
Q2 2023	73.2	+36.8	+101%	Jun 30, 2023
Q1 2023	66.2	+36.2	+121%	Mar 31, 2023
Q4 2022	54.8	+25.3	+86.1%	Dec 31, 2022
Q3 2022	42.5			Sep 30, 2022
Q2 2022	36.4			Jun 30, 2022
Q1 2022	29.9			Mar 31, 2022
Q4 2021	29.4			Dec 31, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.